PUBLISHER: BCC Research | PRODUCT CODE: 1545633
PUBLISHER: BCC Research | PRODUCT CODE: 1545633
The global market for live cell imaging is expected to grow from $2.9 billion in 2024 and is projected to reach $4.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
The North American market for live cell imaging is expected to grow from $1.1 billion in 2024 and is projected to reach $1.7 billion by the end of 2029, at a CAGR of 8.3% during the forecast period of 2024 to 2029.
The Asia-Pacific market for live cell imaging is expected to grow from $757.3 million in 2024 and is projected to reach $1.2 billion by the end of 2029, at a CAGR of 9.2% during the forecast period of 2024 to 2029.
This report covers the worldwide market for live cell imaging, which consists of various instruments, consumables, software and services offered by companies operating in the market. Based on components, the market is divided into instruments and software, consumables and services. By technology, the market is segmented into time-lapse microscopy, fluorescence resonance energy transfer (FRET), fluorescence recovery after photobleaching (FRAP), high-content screening (HCS) and other technologies. Based on end users, it is divided into pharmaceutical and biotechnology companies, academic research institutes and contract research organizations.
By geography, the market in this report is divided into four regions: North America, Europe, Asia-Pacific and Rest of the World (RoW). For market estimates, data has been provided for 2023 as the base year, with forecasts for 2024 through 2029.
The report also covers supply chain analysis, innovative research, opportunities within the market and profiles of leading companies in the live cell imaging industry.